ClinicalTrials.gov record
Enrolling by invitation No phase listed Observational

A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

ClinicalTrials.gov ID: NCT05718570

Public ClinicalTrials.gov record NCT05718570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 9:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-national, Multi-centre, Prospective, Single-arm, Observational, Non-interventional Post-authorisation Safety Study to Investigate Long-term Safety of Sogroya® (Somapacitan) in Adults With Growth Hormone Deficiency (AGHD) Under Routine Clinical Practice

Study identification

NCT ID
NCT05718570
Recruitment status
Enrolling by invitation
Study type
Observational
Phase
Not listed
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • Somapacitan Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2, 2023
Primary completion
Dec 14, 2032
Completion
Dec 14, 2032
Last update posted
Apr 8, 2026

2023 – 2032

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
Keck Medical Center of USC - Outpatient Clinic Los Angeles California 90033
UCLA Health Los Angeles California 90095
Stanford Univ School of Med Palo Alto California 94304
Advanced Rx Clinical Research Westminster California 92683
Anschutz Outpatient Pavilion Aurora Colorado 80045
Metabolic Research Institute Inc West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30318
Northwestern Medical Group Chicago Illinois 60642
Johns Hopkins University Baltimore Maryland 21287
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Brigham & Women's Hospital Boston Massachusetts 02115
Washington University St Louis Missouri 63110
UNMC Omaha Nebraska 68198
Palm Research Center Inc-Vegas Las Vegas Nevada 89148
Northern Nevada Endocrinology Reno Nevada 89511
NYU Langone Orthopedic Center New York New York 10017
Cornell University New York New York 10021
University of North Carolina Chapel Hill North Carolina 27514
Physicians East Endocrinology Greenville North Carolina 27834
Oregon Health & Science University Portland Oregon 97239
St Lukes Physician Group Center Valley Pennsylvania 18034
Revival Research Institute, LLC Dallas Texas 75231
UT Southwestern Medical Center-CRU Dallas Texas 75390
EP Premier Medical Group PA El Paso Texas 79935
Consano Clinical Research, LLC Shavano Park Texas 78231
Puget Sound VA, University of Washington Seattle Washington 98108-1597
University Of Washington_Seattle Seattle Washington 98195-6165

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05718570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05718570 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →